Application of immunohistochemistry to the diagnosis of malignant mesothelioma.
about
Malignant mesotheliomaPromotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubesTenascin-X is a novel diagnostic marker of malignant mesotheliomaThe development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapyHuman malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells.The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in ratsDifferentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles.HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma.Phenotypes and karyotypes of human malignant mesothelioma cell lines.Malignant peritoneal mesothelioma presenting with persistent high fever.The immunohistochemical characterization of sarcomatoid malignant mesothelioma of the pleura.Decidualized ovarian mass mimicking malignancyPINCH-2 expression in cancers involving serosal effusions using quantitative PCR.Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.ERG expression in epithelioid sarcoma: a diagnostic pitfallNeurochemical Markers in the Mammalian Brain: Structure, Roles in Synaptic Communication, and Pharmacological Relevance.Genomic Deletion of and Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures
P2860
Q21202901-F0440B1D-6BE0-4399-A1B0-DE9C2398476BQ23916996-90C1C784-76E6-40D1-BA0B-A08FA9DA9F70Q24649948-3B6E0DD6-118A-4E50-8330-37C6DE3DD666Q27314606-C0E8BC73-5951-4AED-8A8B-3507E0ED0F57Q27333517-66094AAD-107D-450E-B99F-1E7B529EAD61Q28382993-E0D012D2-E612-42EA-B128-4BC1E5A0C4EEQ30490697-5A4B9312-B5E5-48D6-AA9A-8C8401D113DDQ30843463-1828CC94-458C-4763-9DD2-68F41C1ACD84Q34629469-EEE2D294-E027-4241-A187-F687854C5943Q34919238-14222C15-8B2C-4CFC-BCED-0E34B27AEC8FQ35232383-B6E2DF58-6710-4281-930C-148379756387Q35549011-134FC679-7B66-44D3-8EA3-E3CC697D8C27Q35576881-D255A931-BFA2-47BE-9A30-8B87B57F88ADQ36270335-ECAFC553-F580-472E-A50A-73F5C362908EQ37170468-71A4085A-E73C-4C8A-9C90-4B5021C1093AQ42380034-6B308756-2967-4989-9D28-7F43B07D5DB9Q57296621-C6B339FD-067E-4367-9A46-65717BA3987F
P2860
Application of immunohistochemistry to the diagnosis of malignant mesothelioma.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Application of immunohistochemistry to the diagnosis of malignant mesothelioma.
@ast
Application of immunohistochemistry to the diagnosis of malignant mesothelioma.
@en
Application of immunohistochemistry to the diagnosis of malignant mesothelioma.
@nl
type
label
Application of immunohistochemistry to the diagnosis of malignant mesothelioma.
@ast
Application of immunohistochemistry to the diagnosis of malignant mesothelioma.
@en
Application of immunohistochemistry to the diagnosis of malignant mesothelioma.
@nl
prefLabel
Application of immunohistochemistry to the diagnosis of malignant mesothelioma.
@ast
Application of immunohistochemistry to the diagnosis of malignant mesothelioma.
@en
Application of immunohistochemistry to the diagnosis of malignant mesothelioma.
@nl
P1476
Application of immunohistochemistry to the diagnosis of malignant mesothelioma.
@en
P2093
Alberto M Marchevsky
P304
P356
10.1043/1543-2165(2008)132[397:AOITTD]2.0.CO;2
P577
2008-03-01T00:00:00Z